Why the study?
Do biomarkers such as D-Dimer, soluble P-selectin, coagulation factor VIII, inflammatory markers, and thrombin generation help predict primary or recurrent VTE and optimize clinical management?
Population
Patients at risk of primary or recurrent venous thromboembolism (VTE)
Design
Review
Authors
Loading...
Biomarker data for VTE risk remain preliminary; leaves open prospective validation before clinical integration.
Do biomarkers such as D-Dimer, soluble P-selectin, coagulation factor VIII, inflammatory markers, and thrombin generation help predict primary or recurrent VTE and optimize clinical management?
Biomarkers such as D-Dimer, soluble P-selectin, and others may play a role in predicting primary and recurrent VTE and optimizing clinical management.
Pabinger et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: